Is Celldex Therapeutics, Inc. (CLDX) a Buy, Sell, or Hold?
NASDAQ : CLDX
Celldex Therapeutics, Inc. — Analyst Ratings
$38.06 USD
-$0.42 (-1.1%)
- Volume
- 855.79K
- Average Volume
- 990.87K
- Market Capitalization
- $2.53B
- P/E Ratio
- -8.91
- Dividend Yield
- 0.00%
- Price Target
- $60.50
- Year High
- $40.30
- Year Low
- $19.72
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $8.92
Analyst Consensus Summary
Consensus Rating
Sell
19 Analysts
Rating Score
2/5
Recommendation Strength
Upside/Downside
-37.1%
vs Current Price
Price Target
$60.50
Average TargetPrice Target Range
Lowest Target
$40.00
-4.8% DOWNSIDE
Average Target
$60.50
Median Estimate
Highest Target
$100.00
-61.9% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 19
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 15 | 4 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Guggenheim | Yatin Suneja | $100 | $35.35 | 2026-07-20 07:07 AM | 182.9% |
| Wells Fargo | Derek Archila | $54 | $32 | 2026-05-13 06:48 AM | 68.8% |